Cocrystal Pharma Inc (COCP)

Swiss National Bank Has $6.76 Million Stock Position in Itron, Inc. (NASDAQ:ITRI) - Defense World

Defense World

Cocrystal Pharma (NASDAQ:COCP) Given Buy Rating at HC Wainwright - Defense World

Defense World

New York State Common Retirement Fund Has $335000 Stake in Brandywine Realty Trust (NYSE:BDN) - Defense World

Defense World

Russell Investments Group Ltd. Purchases 129182 Shares of Gambling.com Group Limited (NASDAQ:GAMB) - Defense World

Defense World

Cocrystal Pharma and RFS Pharma Merge to Create Advanced Antiviral Development Organization - Yahoo Eurosport UK

Yahoo Eurosport UK

Influenza Pipeline Assessment, 2024 Updates: FDA, EMA, and PMDA Approvals, Emerging Drugs, Clinical Trials, and ... - openPR

openPR

Cocrystal Pharma stock maintains price target, Outperform rating - Investing.com Canada

Investing.com Canada

Cocrystal Pharma Reports First Quarter 2024 Financial Results and Provides Updates on its Antiviral Drug ... - wallstreet:online

wallstreet:online

Cocrystal Pharma Receives Investment Through Private Placement - Yahoo News UK

Yahoo News UK

Hepatitis C Market Forecast 2032: FDA, EMA, PDMA Approvals, Epidemiology, Therapies, Clinical Trials and ... - openPR

openPR

Closing Bell: TD Global Healthcare Leaders Index ETF up on Tuesday (TDOC) - The Globe and Mail

The Globe and Mail

Influenza Pipeline Analysis 2024: FDA Approvals, Clinical Trials, Therapies, Mechanism of Action, Route of ... - openPR

openPR

Cocrystal Pharma Advances Promising Influenza A Drug - TipRanks.com - TipRanks

TipRanks

Columbia Banking System, Inc. (NASDAQ:COLB) Given Average Recommendation of “Hold” by Analysts - Defense World

Defense World

Zacks Research Brokers Cut Earnings Estimates for Murphy USA Inc. (NYSE:MUSA) - Defense World

Defense World

COCP: Topline Data for Influenza A and Dual Coronavirus/Norovirus Programs Expected in 2024; Model Revision ... - Zacks Small Cap Research

Zacks Small Cap Research

Cocrystal Pharma Reports 2023 Financial Results and Provides Updates on its Antiviral Drug-Development Programs

GlobeNewswire Inc.

Cocrystal Pharma Advances Influenza A Treatment Development - TipRanks.com - TipRanks

TipRanks

Cocrystal Pharma Receives Pre-IND Responses from the FDA on Oral CC-42344 for Treating Influenza A

GlobeNewswire Inc.

The Anticipated Breakthrough: The Race for a Norovirus Vaccine - Medriva

Medriva

ClinConnect Partners with Conduit Pharmaceuticals on Cocrystal Development Program for AZD1656 - Business Wire

Business Wire

CDI-988 enters development as oral norovirus therapy - BioWorld Online

BioWorld Online

Cocrystal formation of niclosamide and urea in supercritical CO2 and impact of cosolvent - ScienceDirect.com

ScienceDirect.com

Cocrystal receives approval for Phase I trial of Covid-19 therapy - Clinical Trials Arena

Clinical Trials Arena

Appellate court rules against Liberty Mutual unit in D&O litigation - Business Insurance

Business Insurance

Cocrystal Pharma and MSD patent describes influenza virus CEN inhibitors - BioWorld Online

BioWorld Online

Theratechnologies Is An Underappreciated HIV-Focused Company, Analyst Says - Yahoo Finance

Yahoo Finance

Adjusting the melting point of an Active Pharmaceutical Ingredient (API) via cocrystal formation enables processing of ... - ScienceDirect.com

ScienceDirect.com

Influenza Pipeline Looks Promising as 100+ Companies Working in the Domain, Assesses DelveInsight - PR Newswire

PR Newswire

Kowa Pharmaceuticals America,Inc. Announces Publication of Phase 3 Data Supporting FDA Approval of SEGLENTIS ... - Business Wire

Business Wire

Hepatitis C Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - GlobalData

GlobalData

Influenza A Virus, H1N1 Subtype Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and ... - GlobalData

GlobalData

Full data published on Evusheld, Astrazeneca's 'last MAb standing' in COVID-19 - BioWorld Online

BioWorld Online

FDA Issues Complete Response Letter to Iterum Therapeutics plc (NASDAQ: ITRM) On Its NDA for Oral Sulopenem - BP Journal

BP Journal

Supplements firm backed by Mark Zuckerberg 'pure hype': short seller - New York Post

New York Post

Gilead's Kite Pharma Collaborates With Shoreline Biosciences For Cell Therapies For Cancer Settings - Yahoo Finance

Yahoo Finance

eToro issues statement on closing of positions - FX News Group

FX News Group

Cocrystal Pharma raises "bought deal" offering to $15M (NASDAQ:COCP) - Seeking Alpha

Seeking Alpha

Aileron Therapeutics Inc (NASDAQ:ALRN) Raises $10.3 Million: Develops Innovative Medicine To Safeguard Cancer ... - BP Journal

BP Journal

Cocrystal Pharma Files For $150 Mln Mixed Shelf Offering - SEC Filing - Reuters

Reuters

Covid-19: Partnerships for coronavirus vaccines development - Pharmaceutical Technology

Pharmaceutical Technology

KSU licenses technology for coronavirus, norovirus compounds - Salina Post

Salina Post

18 Medical Stocks To Watch Amid The Coronavirus Outbreak - Novavax (NASDAQ:NVAX), Inovio Pharmaceuticals - Benzinga

Benzinga

Emory HIV/AIDS drug inventor, entrepreneur decorated with French Legion of Honor - Emory News Center

Emory News Center

Ex-Teva Chairman, Blockchain Investor Accused of Pump-and-Dump Scheme - The Wall Street Journal

The Wall Street Journal

Insoluble drug delivery strategies: review of recent advances and business prospects - ScienceDirect.com

ScienceDirect.com

Jane Hsiao Net Worth - TheRichest

TheRichest

Institute of Human Virology honors Schinazi with Lifetime Achievement Award - Emory News Center

Emory News Center